Daratumumab

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2434 publications

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

Journal: Leukemia & lymphoma

Published: September 06, 2026

Subcutaneous Daratumumab in Recurrent Posttransplant Focal Segmental Glomerulosclerosis: A Report of 2 Cases.

Subcutaneous Daratumumab in Recurrent Posttransplant Focal Segmental Glomerulosclerosis: A Report of 2 Cases.

Journal: Kidney medicine

Published: September 05, 2026

IgG4-related disease - treatment with anti-CD20, anti-CD19 antibodies, and other new drugs.

IgG4-related disease - treatment with anti-CD20, anti-CD19 antibodies, and other new drugs.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: August 28, 2026

Daratumumab in AL amyloidosis: survival, cardiac CR, and beyond.

Daratumumab in AL amyloidosis: survival, cardiac CR, and beyond.

Journal: Blood

Published: August 27, 2026

Hemophagocytic Lymphohistiocytosis as a Clinical Harbinger of Rapid Disease Progression in Multiple Myeloma During Daratumumab-Based Therapy.

Hemophagocytic Lymphohistiocytosis as a Clinical Harbinger of Rapid Disease Progression in Multiple Myeloma During Daratumumab-Based Therapy.

Journal: Internal medicine (Tokyo, Japan)

Published: August 26, 2026

First report of daratumumab interference in urine immunofixation electrophoresis confirmed by the HYDRASHIFT 2/4 Daratumumab assay.

First report of daratumumab interference in urine immunofixation electrophoresis confirmed by the HYDRASHIFT 2/4 Daratumumab assay.

Journal: Annals of clinical biochemistry

Published: August 21, 2026

Sequential anti-CD20 monoclonal antibody and daratumumab for refractory nephrotic syndrome in 2 children

Sequential anti-CD20 monoclonal antibody and daratumumab for refractory nephrotic syndrome in 2 children

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: August 17, 2026

CD38+ T-Cell Count Is an Immunologic Phenotype Associated With Blood Pressure.

CD38+ T-Cell Count Is an Immunologic Phenotype Associated With Blood Pressure.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: August 17, 2026

Daratumumab to treat antibody mediated rejection in the absence of donor specific antibodies: Do we need an update in our vocabulary or mental model?

Daratumumab to treat antibody mediated rejection in the absence of donor specific antibodies: Do we need an update in our vocabulary or mental model?

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: August 17, 2026

Limited duration of dexamethasone in newly diagnosed AL amyloidosis: impact on response, toxicity, and survival.

Limited duration of dexamethasone in newly diagnosed AL amyloidosis: impact on response, toxicity, and survival.

Journal: Annals of medicine

Published: August 07, 2026

Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?

Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?

Journal: Expert review of hematology

Published: August 05, 2026

Improvement of chylothorax after lymphangiography in AL amyloidosis

Improvement of chylothorax after lymphangiography in AL amyloidosis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 03, 2026

Showing 1-12 of 2,434

Last Updated: 09/26/2026